RMFEX
Price
$58.54
Change
-$0.03 (-0.05%)
Updated
Sep 20 closing price
VVIAX
Price
$67.77
Change
-$0.05 (-0.07%)
Updated
Sep 20 closing price
Ad is loading...

RMFEX vs VVIAX

Header iconRMFEX vs VVIAX Comparison
Open Charts RMFEX vs VVIAXBanner chart's image
American Funds American Mutual R4
Price$58.54
Change-$0.03 (-0.05%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$67.77
Change-$0.05 (-0.07%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RMFEX vs VVIAX Comparison Chart
Loading...
VS
RMFEX vs. VVIAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFEX is a Buy and VVIAX is a Buy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 183B vs. RMFEX (105B). VVIAX pays higher dividends than RMFEX: VVIAX (2.36) vs RMFEX (1.95). RMFEX was incepted earlier than VVIAX: RMFEX (22 years) vs VVIAX (24 years). RMFEX is a more actively managed with annual turnover of: 25.00 vs. VVIAX (10.00). RMFEX has a lower initial minimum investment than VVIAX: RMFEX (250) vs VVIAX (3000). VVIAX (24.02) and RMFEX (23.63) have marching annual gain over last year. VVIAX return over 5 years is better than : 55.46 vs. RMFEX (51.72).
RMFEXVVIAXRMFEX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years24 years-
Gain YTD16.65316.303102%
Front LoadN/AN/A-
Min. Initial Investment25030008%
Min. Initial Investment IRAN/AN/A-
Net Assets105B183B57%
Annual Yield % from dividends1.952.3683%
Returns for 1 year23.6324.0298%
Returns for 3 years24.5828.2987%
Returns for 5 years51.7255.4693%
Returns for 10 years79.18114.0469%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VNOM45.660.21
+0.46%
Viper Energy
AUGX2.33N/A
N/A
Augmedix
TERN10.02-0.02
-0.20%
Terns Pharmaceuticals
STLD119.83-0.26
-0.22%
Steel Dynamics
TNXP0.15N/A
-1.67%
Tonix Pharmaceuticals Holding Corp.